Department of Pharmacology & Toxicology, October 6 University, 12585 Giza, Egypt.
Department of Pharmacology &Therapeutics, Pharos University in Alexandria, Alexandria, Egypt.
Int Immunopharmacol. 2021 Mar;92:107362. doi: 10.1016/j.intimp.2020.107362. Epub 2021 Jan 13.
Rheumatoid arthritis is a progressive inflammatory disease with multiple dysfunctional intracellular signaling pathways that necessitate new approaches for its management. Hence, the study aimed to inspect the ability of the combination therapy of metformin and omega-3 to modulate different signaling pathways and micro RNAs such as (miR-155, miR-146a and miR-34) as new targets in order to mitigate adjuvant-induced arthritis and compare their effect to that of methotrexate.
Fourteen days post adjuvant injection, Sprague-Dawley rats were treated orally with metformin (200 mg/kg/day) and/or omega-3 (300 mg/kg/day) or intraperitoneally with methotrexate (2 mg/kg/week) for 4 weeks.
All drug treatments amended the arthrogram score and hind paw swelling as well as decreased serum tumor necrosis factor (TNF)-α and interleukin (IL)-1β levels. On the molecular level, all therapies activated phospho-5'adenosine monophosphate-activated protein kinase (p-AMPK) and protein phosphatase 2A (PP2A), while they inhibited phospho-mammalian target of rapamycin (p-mTOR), phospho-signal transducers and activators of transcription (p-STAT3), nuclear factor (NF)-κB p65 subunit, phosho38 mitogen-activated protein kinase (p38 MAPK) and phospho- c-Jun N-terminal kinase (p-JNK). In addition, they decreased the elevated expression level of miRNA-155, 146a and increased the expression level of miRNA-34 and they decreased the expression level of retinoic acid receptor related orphan receptor γT (RORγT) and increased that of fork head box P3 (FOXP3), correcting Th17/Treg cells balance. On most of the aforementioned parameters, the effect of the combination therapy was comparable to that of methotrexate, emphasizing that this combination possesses better additive anti-inflammatory effect than either drug when used alone. In addition, the combination was capable of normalizing the serum transaminases levels as compared to untreated group offering hepatoprotective effect and suggesting the possibility of its use as a replacement therapeutic strategy for MTX in rheumatoid arthritis.
类风湿关节炎是一种进行性炎症性疾病,存在多种功能失调的细胞内信号通路,这需要新的方法来治疗。因此,本研究旨在检查二甲双胍和欧米伽-3 联合治疗调节不同信号通路和 microRNAs(如 miR-155、miR-146a 和 miR-34)的能力,作为新的靶点,以减轻佐剂诱导的关节炎,并将其疗效与甲氨蝶呤进行比较。
在佐剂注射后 14 天,Sprague-Dawley 大鼠经口给予二甲双胍(200mg/kg/天)和/或欧米伽-3(300mg/kg/天),或腹腔内给予甲氨蝶呤(2mg/kg/周),治疗 4 周。
所有药物治疗均改善了关节造影评分和后爪肿胀,降低了血清肿瘤坏死因子-α和白细胞介素-1β水平。在分子水平上,所有疗法均激活了磷酸 5'-单磷酸腺苷激活蛋白激酶(p-AMPK)和蛋白磷酸酶 2A(PP2A),同时抑制了磷酸雷帕霉素靶蛋白(p-mTOR)、磷酸信号转导和转录激活因子(p-STAT3)、核因子(NF)-κB p65 亚单位、磷酸化丝裂原激活蛋白激酶(p38 MAPK)和磷酸化 c-Jun N 端激酶(p-JNK)。此外,它们降低了 miRNA-155、146a 的高表达水平,增加了 miRNA-34 的表达水平,降低了维甲酸受体相关孤儿受体γT(RORγT)的表达水平,增加了叉头框 P3(FOXP3)的表达水平,纠正了 Th17/Treg 细胞平衡。在大多数上述参数中,联合治疗的效果与甲氨蝶呤相当,这强调了与单独使用任何一种药物相比,这种联合治疗具有更好的抗炎作用。此外,与未治疗组相比,联合治疗还能使血清转氨酶水平正常化,发挥肝保护作用,提示其可能作为类风湿关节炎的替代治疗策略来替代甲氨蝶呤。